Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8
|
pubmed:dateCreated |
1985-9-4
|
pubmed:abstractText |
In a prospective, single-blind, randomized study, a single 2-g dose of metronidazole was compared with a seven-day course of 500 mg given twice daily in the treatment of symptomatic vaginal discharge associated with Gardnerella vaginalis. Based on resolution of symptoms and on cultures negative for G vaginalis, 86% (40/46) of women treated with the single dose and 97% (35/36) of women treated with the seven-day course were considered cured at seven to ten days after treatment. Evaluation at 21 days after treatment, however, indicated that only 46% (16/34) of patients treated with the single 2-g dose were considered cured compared with 86% (26/30) of those treated with the seven-day course. Treatment of sexual contacts did not significantly improve cure rates in either group.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0098-7484
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
254
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1046-9
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3894707-Adolescent,
pubmed-meshheading:3894707-Adult,
pubmed-meshheading:3894707-Bacteriological Techniques,
pubmed-meshheading:3894707-Drug Administration Schedule,
pubmed-meshheading:3894707-Female,
pubmed-meshheading:3894707-Gardnerella vaginalis,
pubmed-meshheading:3894707-Haemophilus Infections,
pubmed-meshheading:3894707-Humans,
pubmed-meshheading:3894707-Male,
pubmed-meshheading:3894707-Metronidazole,
pubmed-meshheading:3894707-Middle Aged,
pubmed-meshheading:3894707-Random Allocation,
pubmed-meshheading:3894707-Sexual Behavior,
pubmed-meshheading:3894707-Vaginitis
|
pubmed:articleTitle |
Comparison of single-dose vs one-week course of metronidazole for symptomatic bacterial vaginosis.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|